The US Attorney's Office, District of New Jersey said the cardiologist and his wife operated a test-referral bribery scheme with Biodiagnostic Laboratory Services
Ahmed El Soury was sentenced for his role in a scheme perpetrated by now-defunct Biodiagnostic Laboratory Services to bribe doctors in return for testing referrals.
The agency is excluding certain advanced diagnostic lab tests and molecular pathology tests from a billing regulation that created administrative headaches for many labs.
BCBS of Louisiana covers around 1.45 million lives. The agreement follows decisions by Louisiana TriCare, Medicare, and Medicaid plans to cover OVA1.
The company also signed OVA1 coverage agreements with Michigan's Joint Venture Hospital Laboratories and Arkansas' QCA Health Plan.
Women's health, drug monitoring,and the company's 23andMe collaboration led organic growth in diagnostics.
ACLA urged the court to reconsider its ruling, arguing that it would be impossible for laboratories to comply with it.
The registry, which has been approved by CMS, is designed to demonstrate quality pathology practices and maximize reimbursements.
Anthem said the automated system is an efficient way to ensure coverage for medically necessary genetic tests, but that's not what genetic counselors have described.
OIG will evaluate data to assess whether PAMA pricing results in market-based rates
The Garage's web-based platform is used exclusively by groups that employ value-based payment models
Smaller labs, hospital outreach labs, and labs servicing high numbers of elderly are thought to face the highest risks.
Piper Jaffray analyst William Quirk said the pricing, which was much higher than expected, will help push CareDx toward profitability.
The biggest losers following the release of the preliminary PAMA rates may be Quest and LabCorp, analysts said today.
The government payor proposed rates that would reduce payment by $670 million, though CMS previously estimated a $390 million cut in 2018.
Project Santa Fe, formed last year by five health system-based labs, aims to share strategies and lab-driven programs for improving patient care with labs in other health systems.
The study is part of an effort to drive health plan coverage for Exosome's ExoDx Prostate IntelliScore prostate cancer test.
Since last year the AMA has issued 23 PLA codes for firms that want to better track use of their tests, but the effect of the codes on improving reimbursement remains to be seen.
BUPA Global and other private health insurers have approved reimbursement for OncoDNA's test, which is intended to provide a complete genetic profile of a patient's tumor.
The final LCD covers AlloSure in renal allograft recipients who have a probability of active renal allograft rejection.